Cargando…
Cell Based Treatment of Autoimmune Diseases in Children
Mesenchymal stem cells have recently been recoined as medicinal signaling cells (MSC) for their ability to promote tissue homeostasis through immune modulation, angiogenesis and tropism. During the last 20 years, there has been a plethora of publications using MSC in adults and to lesser extent neon...
Autores principales: | Jones, Olcay Y., McCurdy, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124972/ https://www.ncbi.nlm.nih.gov/pubmed/35615628 http://dx.doi.org/10.3389/fped.2022.855260 |
Ejemplares similares
-
Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series
por: Wong, Stephen C., et al.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis—A Critical Review of Its Pathogenesis and Treatment
por: McMurray, Jeremy C., et al.
Publicado: (2020) -
Allergy and autoimmunity in children: non-mutually exclusive diseases. A narrative review
por: D’Auria, Enza, et al.
Publicado: (2023) -
Low Prevalence of Anti-DFS70 Antibodies in Children With ANA-Associated Autoimmune Disease
por: Freudenhammer, Mirjam, et al.
Publicado: (2022) -
Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease
por: Guilherme, Luiza, et al.
Publicado: (2015)